Tuesday, October 17, 2006

Salubriously ‘Effervescent’

IIPM BEST MBA INSTITUTE
Investment in R&D, as well as the development of new drug molecules, has not been a paramount directive for the industry. Generics have formed the backbone, and the country has excelled at that, leaving patented original developments outside its purview. Providing cheaper and good quality derivatives to the masses in India and other third world countries, today there are about 20,000 registered manufacturers across the country manufacturing medicines worth $300 billion. Liberalisation of the economy has further helped the industry, as now duties on expensive imported equipment vital for manufacturing have come down considerably. The country is home to corporations like Ranbaxy, Cipla, Wockhardt and Dr. Reddy’s Labs, which have established themselves as trusted multinationals with operations spreading magnanimously to the European & American continents.

For Complete IIPM Article, Click on IIPM Article

Source : IIPM Editorial, 2006, Arindam Chaudhuri's Initiative

For More IIPM Article, Visit Below....
IIPM MANAGEMENT INSTITUTE
News At Work (continued alongside) : IIPM
IIPM : WHAT’S SECURITISATION?
IIPM Students Life > Campus Placement
IIPM Academics : Global Outreach Program
IIPM Students Life > Campus Resources
IIPM Alliances
IIPM Rankings

No comments: